PALATIN TECHNOLOGIES INC (PTNT) - Dilution Analysis

10-Q filing | 1.0M shares outstanding

8-K filing: Palatin Technologies, Inc. closed on the exercise of the over-allotment option by the Underwriters in connection with the Company's firm commitment public offering, resulting in additional gross proceeds of approximately $2.37 million. ($18.79M proceeds)

S-1/A filing: This is a firm commitment public offering of common stock, Series J common stock purchase warrants, and Series K common stock purchase warrants. It also includes the opportunity for certain purchasers to purchase pre-funded warrants in lieu of shares of common stock.

S-1/A filing: The company issued and sold Series B and Series C Preferred Stock with warrants, raising $15,000,000, which was later redeemed.

10-K filing | 0.9M shares outstanding

8-K filing: Stock split 1-for-50 | Outstanding: 526,891 → 10,537

8-K filing: Stock split one-for-fifty | Outstanding: 526,891 → 10,537

8-K filing: Stock split 1-for-50 | Outstanding: 26,344,584 → 526,891

8-K filing: Palatin Technologies, Inc. closed a private placement on June 13, 2025, issuing Series D Convertible Preferred Stock and Series I common stock purchase warrants for gross proceeds of $340,000, with the intention to use the net proceeds for general working capital purposes. ($0.34M proceeds)

10-Q filing | 26.3M shares outstanding

8-K filing: Palatin Technologies, Inc. entered into a securities purchase agreement to sell and issue 76,666,667 shares of common stock at $0.15 per share in a registered public offering, along with common stock equivalents and warrants to purchase additional shares, with gross proceeds expected to be $11.5 million for general working capital purposes. ($11.5M proceeds)

S-1/A filing: This S-1/A filing relates to the offering of up to 57,339,449 shares of common stock and accompanying warrants, or pre-funded warrants and accompanying warrants, for working capital and general corporate purposes, including development work on bremelanotide and tirzepatide combination.

RW filing: This RW filing withdraws the request for acceleration of the effective date of the registration statement, indicating that the company is no longer requesting the Registration Statement to be declared effective at this time.

S-1 filing: This S-1 filing details a reasonable best efforts offering of common stock and warrants, or pre-funded warrants and warrants, with the net proceeds intended for working capital and general corporate purposes, including development work on a combination of bremelanotide and tirzepatide.

10-Q filing | 23.5M shares outstanding

8-K filing: Palatin Technologies, Inc. entered into a securities purchase agreement to sell 2,550,000 shares of common stock and pre-funded warrants to purchase up to 2,138,000 shares of common stock in a registered direct offering, along with unregistered common stock purchase warrants to purchase up to 4,688,000 shares of common stock in a concurrent private placement, with gross proceeds of approximately $4.7 million. ($4.69M proceeds)

8-K filing: The company entered into an inducement letter with an exercising holder to induce the exercise of existing warrants for 3,907,679 shares of common stock at an adjusted price of $0.875, in exchange for Series C and Series D warrants. ($3.4M proceeds)

10-Q filing | 19.8M shares outstanding

S-1/A filing: This prospectus relates to the offer and sale by the selling stockholders of up to an aggregate of 4,849,915 shares of common stock of Palatin Technologies, Inc., consisting of shares issuable upon exercise of Series A and Series B common stock purchase warrants.

10-K filing | 11.7M shares outstanding

S-1 filing: This prospectus relates to the offer and sale by the selling stockholders of up to an aggregate of 4,849,915 shares of common stock, consisting of shares issuable upon exercise of Series A and Series B common stock purchase warrants.

8-K filing: The Company entered into an agreement with an Exercising Holder to exercise Existing Warrants to purchase 3,233,277 shares of common stock at a reduced price of $1.88 per share, and in exchange, the Company will issue 4,849,915 warrants to purchase shares of common stock. ($6.1M proceeds)

10-Q filing | 16.1M shares outstanding

S-1 filing: This S-1 filing relates to the offer and sale of up to 1,923,078 shares of common stock by selling stockholders, consisting of shares issuable upon exercise of common stock purchase warrants and placement agent warrants.

10-Q filing | 11.7M shares outstanding

8-K filing: Palatin Technologies, Inc. sold 1,831,503 shares of common stock at $5.46 per share in a registered direct offering and issued unregistered warrants to purchase up to 1,831,503 shares, with net proceeds of approximately $9.2 million used for general working capital purposes; also issued placement agent warrants to purchase up to 91,575 shares of common stock. ($10.0M proceeds)

S-1 filing: This S-1 filing describes the offering of up to 2,476,416 shares of common stock by selling stockholders, consisting of shares issuable upon exercise of warrants issued in connection with a previous financing.

10-Q filing | 11.7M shares outstanding

8-K filing: Palatin Technologies, Inc. closed a registered direct offering on October 24, 2023, involving the sale of common stock and pre-funded warrants, along with a concurrent private placement of unregistered warrants, for net proceeds of $4.5 million to be used for general corporate purposes.

10-K filing | 9.3M shares outstanding

10-Q filing | 9.3M shares outstanding

10-Q filing | 9.3M shares outstanding

8-K filing: Palatin Technologies, Inc. extended its manufacturing agreement with Lonza Ltd. until June 30, 2024, and redeemed all outstanding Series B and Series C Convertible Redeemable Preferred Stock for $15,750,000. ($15.75M proceeds)

10-Q filing | 9.3M shares outstanding

8-K filing: Palatin Technologies, Inc. entered into a securities purchase agreement to sell 1,020,000 shares of common stock, pre-funded warrants to purchase up to 798,182 shares, and common warrants to purchase up to 1,818,182 shares in a registered direct offering that closed on November 2, 2022, with net proceeds of approximately $9.1 million.

S-3/A filing: Palatin Technologies files an S-3/A to offer up to $100,000,000 of common stock, preferred stock, debt securities, warrants, purchase contracts or units in any combination.

10-K filing | 9.2M shares outstanding

8-K filing: Stock split 1-for-25 | Outstanding: 230,049,691 → 9,280,000

10-Q filing | 230.0M shares outstanding

10-Q filing | 230.0M shares outstanding

S-3 filing: Palatin Technologies, Inc. is offering an aggregate of $100,000,000 of common stock, preferred stock, debt securities, warrants, purchase contracts or units in any combination of the foregoing.

10-Q filing | 230.0M shares outstanding

10-K filing | 231.3M shares outstanding

10-Q filing | 229.3M shares outstanding

10-Q filing | 229.3M shares outstanding

10-Q filing | 229.3M shares outstanding

10-K filing | 160.5M shares outstanding

10-Q filing | 226.8M shares outstanding

10-Q filing | 226.8M shares outstanding